CIK 0000105770 · Large accelerated filer
WEST PHARMACEUTICAL SERVICES INC
Sign in to watch- Ticker
- WST
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- PA
- Entity type
- operating
- EIN
- 231210010
- Phone
- 6105942900
- Business address
- 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
- Former names
- WEST CO INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,443,749
- in 2 filings, $2.7M under 10b5-1 plans
Net −$5,443,749. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-23 | FRIEL ROBERT F Director | Grant or award | +564 | 3,610.98 | ||
| 2024-04-23 | Feehery William F Director | Grant or award | +564 | 30,292.13 | ||
| 2024-04-23 | BUTHMAN MARK A Director | Grant or award | +564 | 41,786.29 | ||
| 2024-04-23 | Hofmann Thomas W Director | Grant or award | +564 | 44,180.39 | ||
| 2024-03-11 | Winters Chad VP, Chief Accounting Officer | Option exercise | +675 | $173.22 | $117K | 2,123.7 |
| 2024-03-11 | Winters Chad VP, Chief Accounting Officer | Sale | −815 | $358.82 | $292K | 1,308.7 |
| 2024-03-11 | Winters Chad VP, Chief Accounting Officer | Option exercise · Stock Options (Right to Buy) | −675 | 896 | ||
| 2024-02-28 | Witherspoon Charles VP & Treasurer | Option exercise | +2,019 | $102.51 | $207K | 3,998.09 |
| 2024-02-28 | Witherspoon Charles VP & Treasurer | Sale | −2,019 | $358.62 | $724K | 1,979.09 |
| 2024-02-28 | Witherspoon Charles VP & Treasurer | Option exercise · Stock Options (Right to Buy) | −2,019 | 529 | ||
| 2024-02-27 | Green Eric Mark President, CEO and Board Chair | Option exercise 10b5-1 | +64,132 | $57.38 | $3.7M | 217,040.12 |
| 2024-02-27 | Green Eric Mark President, CEO and Board Chair | Sale 10b5-1 | −64,132 | $359.85 | $23.1M | 152,908.12 |
| 2024-02-27 | Green Eric Mark President, CEO and Board Chair | Option exercise 10b5-1 | +9,000 | $57.38 | $516K | 152,908.12 |
| 2024-02-27 | Green Eric Mark President, CEO and Board Chair | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,000 | 9,316 | ||
| 2024-02-27 | Green Eric Mark President, CEO and Board Chair | Option exercise · Stock Option (Right to Buy) 10b5-1 | −64,132 | 15,684 | ||
| 2024-02-23 | Abraham Silji SVP, Chief Technology Officer | Option exercise | +7,012 | $173.22 | $1.2M | 11,672.26 |
| 2024-02-23 | Abraham Silji SVP, Chief Technology Officer | Sale | −7,012 | $365.00 | $2.6M | 4,660.26 |
| 2024-02-23 | Abraham Silji SVP, Chief Technology Officer | Option exercise · Stock Options (Right to Buy) | −7,012 | 0 | ||
| 2024-02-20 | Witherspoon Charles VP & Treasurer | Grant or award | +144 | 1,979.09 | ||
| 2024-02-20 | Witherspoon Charles VP & Treasurer | Grant or award · Stock Options (Right to Buy) | +742 | 742 |
Page 11 of 13 · 257 trades